DECRYPTION – The financial incentive in public health continues to raise moral questions, but a study finds no adverse effects in the medium term.
Being paid for treatment goes against what we are used to – usually it is the patient who pays the doctor, directly or through their contributions. But this is indeed the logic of the financial incentive in public health, a method aimed at increasing the participation of populations in certain medical acts by remunerating them – for example, by giving them 20 euros after a screening for cancer. Experimented in different contexts and countries, in its infancy in France, this strategy still raises questions. Is it wise to pay a person to submit to an act which, a priori, will be beneficial to him? Are we not harming the public’s perception of the relevance and safety of the medical procedure in question? Is there a gain for the community?
Swiss and Swedish researchers have tried to answer these questions through vaccination campaigns against Covid-19. And their results, published Wednesday in the journal Natureare rather in…
This article is for subscribers only. You have 85% left to discover.
Pushing back the limits of science is also freedom.
Keep reading your article for €0.99 for the first month
Already subscribed? Login